0MSD.L LSE
CompuGroup Medical SE & Co. KGaA
1W: +inf%
1M: -0.9%
3M: +0.5%
YTD: +2.4%
€41.50
Last traded 2026-06-30 — delisted
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Income Trends
Revenue
$1.2B
-2.8% ▼
5Y CAGR: +9.1%
Gross Profit
$965M
-4.0% ▼
5Y CAGR: +31.0%
Operating Income
$106M
-14.0% ▼
5Y CAGR: -2.3%
Net Income
$35M
-24.6% ▼
5Y CAGR: -12.1%
EPS (Diluted)
$0.66
-25.0% ▼
5Y CAGR: -13.1%
EBITDA
$207M
-4.1% ▼
5Y CAGR: +3.3%
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $837M | $1.0B | $1.1B | $1.2B | $1.2B |
| YoY Growth | +12.3% | +22.5% | +10.2% | +5.1% | -2.8% |
| Cost of Revenue | $124M | $739M | $172M | $183M | $189M |
| Gross Profit | $713M | $286M | $958M | $1.0B | $965M |
| Gross Margin | 85.2% | 27.9% | 84.8% | 84.6% | 83.6% |
| R&D Expenses | $0 | $124M | $0 | $0 | $0 |
| SG&A Expenses | $43M | $46M | $45M | $38M | $35M |
| Operating Expenses | $588M | $763M | $851M | $882M | $859M |
| Operating Income | $125M | $109M | $107M | $123M | $106M |
| Operating Margin | 15.0% | 10.6% | 9.5% | 10.4% | 9.2% |
| Interest Expense | $8M | $8M | $12M | $24M | $33M |
| Income Before Tax | $110M | $98M | $107M | $73M | $62M |
| Tax Expense | $37M | $29M | $33M | $26M | $27M |
| Net Income | $73M | $69M | $73M | $46M | $35M |
| Net Margin | 8.7% | 6.7% | 6.5% | 3.9% | 3.0% |
| EPS (Diluted) | $1.36 | $1.30 | $1.40 | $0.88 | $0.66 |
| EBITDA | $192M | $214M | $228M | $213M | $207M |
| Shares Outstanding | 54M | 53M | 52M | 52M | 53M |